New insights into the immunology of chronic obstructive pulmonary disease. (Q37930203)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907865%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

review article

1 reference

title

New insights into the immunology of chronic obstructive pulmonary disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907865%20AND%20SRC:MED&resulttype=core&format=json

chronic obstructive pulmonary disease

12 February 2020

main subject

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907865%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Guy G Brusselle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907865%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Guy F Joos

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907865%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

English

0 references

publication date

1 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907865%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907865%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

378

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907865%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

9795

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907865%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

1015-1026

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907865%20AND%20SRC:MED&resulttype=core&format=json

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Burden and clinical features of chronic obstructive pulmonary disease (COPD).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Chronic obstructive pulmonary disease in non-smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

The pathology of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Oxidative stress and redox regulation of lung inflammation in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Cigarette smoke induces senescence in alveolar epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Immunologic aspects of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Innate immune recognition in infectious and noninfectious diseases of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Extracellular adenosine triphosphate and chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Autophagy protein microtubule-associated protein 1 light chain-3B (LC3B) activates extrinsic apoptosis during cigarette smoke-induced emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Elevated MMP-12 protein levels in induced sputum from patients with COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Airway mucus function and dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Transgenic and gene-targeted mice as models for chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

The development of emphysema in cigarette smoke-exposed mice is strain dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Innate immune processes are sufficient for driving cigarette smoke-induced inflammation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Alterations in lung mast cell populations in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Innate or adaptive immunity? The example of natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Close encounters of different kinds: dendritic cells and NK cells take centre stage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

The role of dendritic and epithelial cells as master regulators of allergic airway inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Acute effects of tobacco smoke on human airway dendritic cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Dendritic cell subsets in primary and secondary T cell responses at body surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Interleukin-18 production and pulmonary function in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Interleukin-17 and type 17 helper T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Antielastin autoimmunity in tobacco smoking-induced emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

CD4-Regulatory Cells in COPD Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Increased T-regulatory cells within lymphocyte follicles in moderate COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

The nature of small-airway obstruction in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Cigarette smoke-induced emphysema: A role for the B cell?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Lymphoid follicles in (very) severe COPD: beneficial or harmful?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Bronchus-associated lymphoid tissue (BALT) structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Plasmacytoid dendritic cells in pulmonary lymphoid follicles of patients with COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

A Novel Insight into Adaptive Immunity in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Regulation of Homeostatic Chemokine Expression and Cell Trafficking During Immune Responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

The development of inducible bronchus-associated lymphoid tissue depends on IL-17.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Infection in the pathogenesis and course of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Disordered microbial communities in asthmatic airways

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Defective macrophage phagocytosis of bacteria in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Microbiologic Determinants of Exacerbation in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Autophagy in immunity and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

New strains of bacteria and exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Autoantibodies in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Anti-tissue antibodies are related to lung function in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Smoke exposure as a determinant of autoantibody titre in 1-antitrypsin deficiency and COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Antinuclear autoantibodies are more prevalent in COPD in association with low body mass index but not with smoking history

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

The impact of the extracellular matrix on inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Hypoxia and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Decreased histone deacetylase activity in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Epigenetic regulation of airway inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

The natural history of chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Molecular mechanisms of corticosteroid resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Immunology of asthma and chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960988-4

7 January 2021

10.1016/S0140-6736(11)60988-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907865%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907865%20AND%20SRC:MED&resulttype=core&format=json